A Texas woman who regrets a double mastectomy she underwent during gender transition can move forward with her lawsuit against the therapist who recommended the surgery, the Texas Supreme Court ruled, reversing lower courts that had thrown the case out on statute-of-limitations grounds.
The decision in Soren Aldaco's case lands at a moment when detransitioner malpractice claims are gaining traction across the country and major medical institutions are pulling back from procedures they once championed. For Aldaco and her legal team, the ruling reopens a courthouse door that had been shut twice before.
Aldaco underwent the double mastectomy in June 2021 after therapist Barbara Wood signed a recommendation letter clearing her for the procedure. But Wood had primarily been treating Aldaco for relationship issues, not gender dysphoria, as Fox News reported. Aldaco's lawsuit alleges that Wood's recommendation amounted to "a severe departure from any recognized standard of care."
The Texas Supreme Court found that the statute of limitations had not expired, reversing the lower courts and allowing the case to proceed. The high court's opinion described what followed the surgery in stark terms.
"She experienced post-surgical complications that required emergency medical care. Research and self-reflection ultimately led her to regret the life-changing and body-altering procedure she'd once embraced."
That language came directly from the court's written opinion. It signals that the justices took seriously both the physical harm Aldaco suffered and the timeline of her realization that the surgery had been a mistake.
The factual core of Aldaco's claim is straightforward but damning. She sought therapy for relationship problems. Wood treated her for those problems. Yet Wood signed a letter recommending Aldaco for an irreversible surgical procedure that removed both breasts. Aldaco alleges that Wood lacked the clinical basis to make that recommendation and that the letter fell far outside accepted professional standards.
Post-surgical complications sent Aldaco to emergency care. Over time, she came to believe the procedure had been wrong for her. The lawsuit that followed was dismissed by two lower courts, each finding that Aldaco had waited too long to file. The Texas Supreme Court disagreed.
The ruling does not resolve the merits of Aldaco's malpractice claim. It decides only that she filed in time and that a court must hear her case. But clearing the procedural hurdle is the step that matters most at this stage. Without it, Aldaco's allegations would never reach a jury.
John Ramer, the attorney representing Aldaco, framed the case as part of a broader pattern of medical failure. In comments reported by the Washington Examiner, Ramer did not mince words.
"What was done to Ms. Aldaco and many people like her is a medical scandal. Kids and young adults suffering from severe psychological distress went looking for help, and what they found is medical providers saying that what's going to liberate them from their distress is pumping them full of cross-sex hormones and cutting off their body parts."
Ramer's language reflects a legal strategy that goes beyond one client. By calling the broader practice a "medical scandal," he is positioning Aldaco's case as a test for accountability across the profession. Whether that argument succeeds at trial remains to be seen, but the Texas Supreme Court has now guaranteed he will get the chance to make it.
Aldaco's case does not exist in isolation. On January 30, a New York jury awarded detransitioner Fox Varian $2 million in what became the first successful malpractice trial involving gender-affirming care performed on a minor. Varian had undergone a double mastectomy at age 16. The verdict sent shockwaves through the medical establishment.
The fallout was rapid. The American Society of Plastic Surgeons and the American Medical Association both reversed their positions, recommending against gender-affirming surgeries for minors. Major hospital systems followed. NYU Langone Health, Baystate Health, and Vanderbilt University Medical Center each discontinued or scaled back transgender care for minors in the weeks after the ruling, as Just The News detailed.
The speed of those reversals tells its own story. Institutions that had treated these procedures as settled medicine abandoned that position almost overnight once a jury attached a price tag to the harm.
The institutional retreat has not gone unnoticed by observers outside the courtroom. Writing in The Atlantic on February 12, Helen Lewis put the shift bluntly: "American doctors are no longer united on the wisdom of medicalizing gender dysphoria in minors."
That fracture matters for cases like Aldaco's. Malpractice claims hinge on the standard of care, the level of treatment a competent professional in the same field would provide. When major medical associations pull back their endorsements, the standard of care shifts with them. What was defensible last year may not be defensible next year.
For plaintiffs' attorneys, the timing is favorable. Every institutional reversal, every withdrawn guideline, and every hospital policy change becomes potential evidence that the old approach fell below professional norms. Defense attorneys will argue that the standard should be judged as of the date of treatment, not the date of trial. That fight will play out case by case.
The Texas Supreme Court's decision is procedural, not substantive. It holds that Aldaco's claims were timely filed. It does not find that Wood committed malpractice. It does not establish new rules for therapists who write recommendation letters for surgical procedures. It does not address whether gender-affirming care is appropriate in any particular case.
What it does is keep the courthouse open. And in litigation, access to a courtroom is often the whole ballgame. Defendants settle cases they might lose at trial. Institutions change policies when they see verdicts and settlements stacking up. The procedural ruling in Aldaco's case carries practical weight far beyond the docket number.
The case will now return to a lower court for proceedings on the merits. Aldaco will need to prove that Wood's recommendation fell below the standard of care, that the surgery caused her harm, and that Wood's conduct was the proximate cause. Those are standard elements of a medical malpractice claim, but the facts she has alleged, if proven, present a compelling set of circumstances for a jury.
Aldaco's case raises a question that courts across the country will face with increasing frequency: Who bears responsibility when a patient undergoes an irreversible procedure and comes to regret it? The surgeon who performed the operation? The therapist who recommended it? The system that treated the pathway as routine?
In Aldaco's framing, the therapist who signed the recommendation letter bears direct responsibility. Wood was not treating Aldaco for gender dysphoria. She was treating her for relationship issues. Yet she put her name on a letter that opened the door to a permanent surgical outcome. Aldaco's legal team will argue that a therapist in that position had a duty to decline, or at minimum to ensure a proper clinical foundation existed before endorsing an irreversible procedure.
Wood's defense has not been detailed in public filings beyond the statute-of-limitations argument that the Texas Supreme Court just rejected. How she defends the substance of the recommendation will shape the next phase of the case.
The Texas case heads back to trial court. The New York verdict against the doctors who operated on Fox Varian may face appeal. Attorneys representing other detransitioners are watching both cases closely, looking for precedent and strategy.
The medical establishment's rapid retreat from its prior positions suggests that institutions already see the legal risk. When the American Medical Association reverses course on a category of procedures within weeks of a single jury verdict, the signal is clear: the professional consensus that once shielded these practices from scrutiny has cracked.
For Aldaco, the fight is personal. She lost both breasts to a procedure she now believes she should never have undergone, recommended by a therapist she trusted to treat an entirely different problem. The Texas Supreme Court has told her she deserves her day in court.
When the people patients trust to protect them become the ones who fast-track irreversible harm, the courtroom may be the only place left where accountability still means something.
